Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant growth hormone fused to hyFc |
|---|---|
| Date Designated: | 11/09/2016 |
| Orphan Designation: | Treatment of growth hormone deficiency. |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Genexine, Inc. 700 Daewangpangyo-ro Korea Bio Pk Bldg B, Bundang-gu Gyeonggi-do South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







